Summary

  • Pro-Dex reported fiscal Q4 2026 sales of $20.4 million and gross profit of $7.1 million. Its gross margin rose to 35% from 20%, helped by next-generation orthopedic-handpiece shipments, product mix, factory absorption and the recently acquired APM machine shop.
  • The comparison is unusually favourable: during most of Q4 2025, Pro-Dex shipped the largest customer’s legacy handpiece because that customer had placed the next-generation model on hold. The hold was released only late in that quarter.
  • One unnamed customer represented 78% of fiscal-year sales and 81% of gross receivables. A contract through 2028 adds duration, but the operating test remains customer orders, product status, mix, collections and the uncertain repair curve of the new handpiece.

The most important number in Pro-Dex’s fiscal 2026 results is not the 17% increase in quarterly sales. It is the 103% increase in gross profit. Sales rose from $17.494 million to $20.405 million, while gross profit rose from $3.490 million to $7.091 million. The reported margin moved from 20% to 35%.

That is a genuine change in the quarter’s economics. Cost of sales fell by $690,000 even as revenue added $2.911 million. A manufacturer filling more of the same cost base with a better product mix should exhibit precisely that kind of operating leverage.

The caution lies in the comparison. Pro-Dex says the higher sales and gross profit were primarily attributable to the largest customer’s next-generation orthopedic handpiece. It also says that, during much of the year-earlier quarter, it had been shipping the customer’s legacy handpiece because the customer maintained a product hold on the new model. Production and shipment of the next-generation handpiece resumed only after the customer released the hold late in that quarter.

The result therefore joins two improvements. Fiscal Q4 2026 contained better volume, mix and absorption. Fiscal Q4 2025 contained an interruption that made the starting point unusually weak. Calling the 15-point margin change entirely structural would ignore the denominator of history; dismissing it as only a base effect would ignore a year of real production.

The customer controls the first production gate

Pro-Dex designs and manufactures powered surgical drivers and shavers, often under exclusive development and supply agreements. Its customer can commission a custom device or ask Pro-Dex to manufacture a customer design. In either case, commercial revenue does not begin with factory availability alone. The customer’s product status, launch schedule, purchase order and inventory policy determine whether the line runs.

The product hold makes that control unusually visible. Pro-Dex does not identify the customer or explain the reason for the hold. It would be wrong to turn the phrase into an allegation of a recall, a regulatory failure or a defect at Pro-Dex. The disclosed fact is narrower: the customer held the next-generation product, then released it and returned Pro-Dex to full production late in fiscal 2025.

By fiscal 2026, the new model was the principal growth engine. Medical-device revenue to the largest customer increased by $15.3 million. Total company revenue increased by only $11.0 million because repair revenue—also principally associated with that customer—fell by $6.0 million as the legacy handpiece receded.

This is not a simple swap of one product for another. A new handpiece can bring higher production revenue and better factory absorption while simultaneously retiring a mature repair pool. Pro-Dex expects billable repairs of the new model to begin in fiscal 2027, but says it does not yet know at what volumes. The transition has two clocks: shipments arrive first; the service tail has to season.

Thirty-five percent contains both mix and absorption

The unrounded Q4 margin was about 34.75%, compared with 19.95% a year earlier. Pro-Dex gives three operating explanations besides the handpiece comparison: favourable product mix, better absorption of indirect manufacturing costs and favourable margins at Advanced Precision Machining, or APM, acquired in February.

Those mechanisms are related but not interchangeable. Product mix asks what was sold. Absorption asks how fixed or indirect manufacturing cost was spread across output. APM introduces a different reporting perimeter. If the next-generation handpiece runs at volume, it can improve the first two. If APM supplies subassemblies internally while earning outside aerospace and defence revenue, it can alter both cost and consolidated mix.

The annual data show the factory effect without making it look effortless. Under-absorption of manufacturing overhead improved to $1.940 million from $2.517 million. But inventory and warranty charges increased to $1.122 million from $264,000, principally because of a larger reserve on a complex machined part used in the same next-generation handpiece.

That reserve is not proof that the model is uneconomic. It is evidence that higher-volume precision manufacturing carries its own yield and inventory risk. A margin recovery built on one complex product should be tested against scrap, reserves, warranty use and the stability of the customer’s production schedule, not merely against headline revenue.

Q4 operating costs also prevent a straight-line extrapolation from gross profit. Operating expenses rose from $2.146 million to $3.562 million. The increase included a $349,000 allowance for uncollectible receivables, $436,000 of APM administrative expense and $250,000 of consulting payments to APM’s founder. Operating income still rose 163% to $3.529 million, but the integrated cost base was not static.

A 78% customer is also an 81% collection exposure

For the full year, Pro-Dex’s largest customer generated $60.742 million, or 78% of sales, up from 75% a year earlier. The top three customers generated 92%. At 30 June, the largest customer accounted for $17.403 million, or 81%, of gross accounts receivable.

The sales figure describes demand concentration; the receivables figure shows that the concentration persists after shipment. It is not evidence of non-payment. It means that the timing of one customer’s purchasing and payment can move factory utilisation, reported revenue and operating cash together.

Accounts receivable increased by $4.713 million during fiscal 2026, absorbing cash even as the income statement improved. Inventory released $1.630 million. Operating cash flow was $7.242 million, reversing a $1.682 million outflow in fiscal 2025. That is useful conversion, but it was materially below $13.662 million of net income.

The net-income comparison also needs its own boundary. Fiscal 2026 included $5.655 million of gains on marketable equity investments, compared with $2.116 million a year earlier. Pro-Dex states that these investments are carried at estimated fair value and can be highly volatile. The $4.12 diluted annual earnings per share should not be treated as a clean measure of manufacturing earnings.

Cash ended the year at $8.192 million, up from $419,000, and working capital reached $40.265 million. The balance sheet is not immediately distressed. Yet the quality of the operating bridge still depends on collecting a receivable book dominated by one counterparty and avoiding a new inventory build if order timing changes.

The 2028 agreement buys time, not independence

During fiscal Q2, the largest customer extended the surgical-handpiece supply agreement through calendar 2028 and committed to higher volumes of the newest model. Pro-Dex says the customer has placed purchase orders for 2027 deliveries and expects similar orthopedic-revenue levels through 2028.

This contract is valuable. It turns an experimental product launch into a multi-year production programme. It supports investment in machinery, people and supplier capacity. It also reduces the near-term probability that the customer relationship simply disappears.

It does not remove concentration. A contract cannot guarantee the customer’s downstream demand, product status, inventory choices or extension beyond 2028. Nor does it specify the margin at every mix and volume. A longer runway makes the production asset easier to plan; it also deepens the amount of capacity whose economics are tied to the same buyer.

Backlog illustrates the distinction. It fell to $32.9 million from $50.4 million a year earlier. Pro-Dex says the decline is a matter of timing and that substantially all year-end backlog, plus certain later orders, should be delivered in fiscal 2027. The company defines backlog as firm acknowledged orders, not all revenue expected under customer contracts.

Both statements can be true: the long-term agreement can remain intact while the point-in-time order book declines. The monitoring mistake would be to use contract duration as a substitute for purchase orders, or to use a lower backlog as proof that the programme has failed. The next evidence is bookings and delivery, not rhetoric around either number.

Buying APM internalises one dependency and creates another perimeter

Pro-Dex bought APM for $8.650 million in February. APM had been a significant supplier and makes several of Pro-Dex’s machined subassemblies. The acquisition was explicitly intended to support higher demand from the extended customer contract, expand manufacturing capacity and broaden the customer base through aerospace and defence work.

The strategic logic is physical. Owning a machine shop can improve scheduling, preserve scarce process knowledge, shorten feedback between design and production and retain supplier margin. It may be especially useful when a single high-volume handpiece requires a complex part whose quality affects inventory reserves.

The first reported contribution is modest relative to the thesis. From acquisition through year-end, APM added $719,000 of revenue and $84,000 of pretax income. The purchase also added $436,000 of separate administrative expense in Q4 and $500,000 of non-recurring consulting expense across the year.

Pro-Dex funded the $6.650 million cash portion with a new term loan and issued a $2.000 million seller note bearing 8% interest. Total notes payable ended at $17.513 million before unamortised fees, compared with $15.431 million a year earlier. The company also excluded APM from its fiscal 2026 internal-control assessment under the permitted first-year acquisition treatment.

None of those facts invalidates the acquisition. They define the proof still required. APM must demonstrate reliable internal supply, outside-customer revenue, consolidated margin and cash generation after its separate costs and debt service. Vertical integration reduces reliance on an external supplier only if the owned asset performs; otherwise a purchasable input becomes a fixed internal obligation.

The next disclosure needs a transition ledger

The useful operating bridge begins with the next-generation handpiece: units or revenue, product status, purchase orders, mix, absorption and reserves. It then shows the fading legacy repair stream and the emerging repair stream of the new model. Finally, it separates APM’s internal supply benefit from APM’s external revenue, cost base and cash.

That would make the 35% margin intelligible without demanding disclosure of a confidential customer name. Investors do not need the identity to see the dependency. They need enough segmentation to know whether the margin comes from a durable manufacturing curve or from comparing an uninterrupted quarter with a hold-affected one.

The constructive scenario is not simply another 35%. It is stable next-generation orders, lower under-absorption, controlled part reserves, on-time collection and visible APM contribution, while new-model repairs begin to replace part of the legacy decline. A mixed scenario keeps revenue high but gives back margin as absorption or mix normalises. The weaker scenario combines a customer schedule change, rising reserves, lower backlog conversion and receivables that absorb cash.

Pro-Dex has earned the right to call fiscal 2026 an operating advance. It has not yet made the margin independent of the customer’s gate. The product is next-generation; the concentration is not.

Sources